Gallop Oncology
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6 Tide St, Boston, Massachusetts, 02210,...Website
www.galloponcology.comRevenue
<$5 MillionIndustry
About Gallop Oncology
Gallop Oncology Org Chart
Is Gallop Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Gallop Oncology launches new products
Check if Gallop Oncology has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Gallop Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Gallop Oncology
Click to see if Gallop Oncology had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Gallop Oncology has new funding data
Check out if Gallop Oncology is spiking on competitors!
Earning: See what the market has to say on Gallop Oncology recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Gallop Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gallop Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gallop Oncology.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gallop Oncology
Gallop Oncology is a clinical-stage biopharma company focused on developing innovative drugs that target galectin-9, a key regulator in cancer processes. Their lead asset, LYT-200, is designed to treat hematologic malignancies such as acute myeloid leukemia and solid tumors like head and neck cancers, utilizing a dual mechanism of direct tumor supp... Read More